Large cohort study confirms link between pioglitazone, bladder cancer

Pioglitazone was linked to a 63% increase in bladder cancer risk, compared with other noninsulin antidiabetic drugs in a large population-based cohort study. Furthermore, incidence rose the longer...
Source: Clinical Endocrinology News - Category: Endocrinology Source Type: news